We evaluated the clinical utility of target-enhanced whole-genome sequencing (TE-WGS) in comparison with targeted panel sequencing (TPS) for identifying clinically relevant genomic alterations in advanced prostate cancer. We applied TE-WGS to tumor/normal paired samples from patients with advanced prostate cancer previously tested with TPS during routine care.
Sangmoon Lee
As seen in:
Nature,
Wiley Online Library,
MDPI,
Taylor & Francis Online,
Cell Reports Medicine,
medRxiv,
UroToday
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Sangmoon
Contact Sangmoon, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack